Articles dans des revues avec comité de lecture (110)
  1. 20. Wolking, S., Moreau, C., McCormack, M., Krause, R., Krenn, M., EpiPGx Consortium,, Berkovic, S. F., Cavalleri, G. L., Delanty, N., Depondt, C., Johnson, M. R., Koeleman, B., Kunz, W. G., Lerche, H., Marson, A. G., O'Brien, T., Petrovski, S., Sander, J. W., Sills, G., Striano, P., Zara, F., Zimprich, F., Sisodiya, S. M., Girard, S., & Cossette, P. (2021). Assessing the role of rare genetic variants in drug-resistant, non-lesional focal epilepsy. Annals of clinical and translational neurology, 8(7), 1376-1387. doi:10.1002/acn3.51374
  2. 21. Wolking, S., Campbell, C., Stapleton, C., McCormack, M., Delanty, N., Depondt, C., Johnson, M., Koeleman, B. B., Krause, R., Kunz, W. W., Marson, A. G., Sander, J. W., Sills, G., Striano, P., Zara, F., Sisodiya, S., Cavalleri, G., & Lerche, H. (2021). Role of Common Genetic Variants for Drug-Resistance to Specific Anti-Seizure Medications. Frontiers in Pharmacology, 12, 688386. doi:10.3389/fphar.2021.688386
  3. 22. Epi25 Collaborative. Electronic address: jm4279@cumc.columbia.edu,, Depondt, C., et al. (2021). Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals. American journal of human genetics, 108(6), 965-982. doi:10.1016/j.ajhg.2021.04.009
  4. 23. Swinnen, L., Chatzichristos, C., Jansen, K., Lagae, L., Depondt, C., Seynaeve, L., Vancaester, E., Van Dycke, A., Macea, J., Vandecasteele, K., Broux, V., De Vos, M., & Van Paesschen, W. (2021). Accurate detection of typical absence seizures in adults and children using a two-channel electroencephalographic wearable behind the ears. Epilepsia. doi:10.1111/epi.17061
  5. 24. Campbell, C., McCormack, M., Patel, S., Stapleton, C., Bobbili, D., Krause, R., Depondt, C., Sills, G., Koeleman, B., Striano, P., Zara, F., Sander, J. W., Lerche, H., Kunz, W. W., Stefansson, K., Stefansson, H., Doherty, C. P., Heinzen, E. E., Scheffer, I. E., Goldstein, D., O'Brien, T. J., Cotter, D., Berkovic, S. F., Sisodiya, S., Delanty, N., & Cavalleri, G. (2021). A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam. Epilepsia. doi:10.1111/epi.17228
  6. 25. Depondt, C., Van Paesschen, W., Van Rijckevorsel, K., Leunikava, I., & Ferrière, F. (2021). Brivaracetam Retention Rate and Seizure Outcomes in Patients with Drug-Resistant Focal Epilepsy Included in the Medical Need Program in Belgium: A Real-World, Multicenter, Chart Review. Drugs - Real World Outcomes. doi:10.1007/s40801-021-00246-7
  7. 26. Larivière, S., Rodríguez-Cruces, R., Royer, J., Caligiuri, M. E., Gambardella, A., Concha, L., Keller, S., Cendes, F., Yasuda, C., Bonilha, L., Gleichgerrcht, E., Focke, N. K., Domin, M., von Podewills, F., Langner, S., Rummel, C., Wiest, R., Martin, P., Kotikalapudi, R., O'Brien, T., Sinclair, B., Vivash, L., Desmond, P. M., Alhusaini, S., Doherty, C. P., Cavalleri, G. L., Delanty, N., Kalviainen, R., Jackson, G. D., Kowalczyk, M., Mascalchi, M., Semmelroch, M., Thomas, R. H., Soltanian-Zadeh, H., Davoodi-Bojd, E., Zhang, J., Lenge, M., Guerrini, R., Bartolini, E., Hamandi, K., Foley, S., Weber, B., Depondt, C., Absil, J., Carr, S. J. A., Abela, E., Richardson, M. P., Devinsky, O. I., Severino, M., Striano, P., Tortora, D., Hatton, S. N., Vos, S. B., Duncan, J. S., Whelan, C. D., Thompson, P. M., Sisodiya, S. M., Bernasconi, A., Labate, A., McDonald, C. R., Bernasconi, N., & Bernhardt, B. C. (2020). Network-based atrophy modeling in the common epilepsies: A worldwide ENIGMA study. Science advances, 6(47). doi:10.1126/sciadv.abc6457
  8. 27. Choi, H., Detyniecki, K., Bazil, C. C., Thornton, S., Crosta, P., Tolba, H., Muneeb, M., Hirsch, L. J., Heinzen, E. L., Sen, A., Depondt, C., Perucca, P., Heiman, G. G., & EPIGEN Consortium, (2020). Development and validation of a predictive model of drug-resistant genetic generalized epilepsy. Neurology, 95(15), e2150-e2160. doi:10.1212/WNL.0000000000010597
  9. 28. Hofer, E., Depondt, C., & ENIGMA, C. (2020). Genetic correlations and genome-wide associations of cortical structure in general population samples of 22,824 adults. Nature communications.
  10. 29. Cisse, F. A., Osman, G., Legros, B., Depondt, C., Hirsch, L., Struck, A. A., & Gaspard, N. (2020). Validation of an algorithm of time-dependent electro-clinical risk stratification for electrographic seizures (TERSE) in critically ill patients. Clinical neurophysiology, 131(8), 1956-1961. doi:10.1016/j.clinph.2020.05.031
  11. 30. Niestroj, L.-M., Depondt, C., Epi25 Collaborative,, et al. (2020). Epilepsy subtype-specific copy number burden observed in a genome-wide study of 17 458 subjects. Brain.
  12. 31. Wolking, S., Moreau, C., Nies, A. A., Schaeffeler, E., McCormack, M., Auce, P., Avbersek, A., Becker, F., Krenn, M., Møller, R. S., Nikanorova, M., Weber, Y. Y., Weckhuysen, S., Cavalleri, G., Delanty, N., Depondt, C., Johnson, M., Koeleman, B., Kunz, W. W., Marson, A. G., Sander, L. J., Sills, G., Striano, P., Zara, F., Zimprich, F., Schwab, M., Krause, R., Sisodiya, S., Cossette, P., Girard, S. S., & Lerche, H. (2020). Testing association of rare genetic variants with resistance to three common antiseizure medications. Epilepsia, 61(4), 657-666. doi:10.1111/epi.16467
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 Suivant >>